Straits Research Logo- p.jpg
Global Drug Infusion System Market Size Grows Steadily at a CAGR of 6.9%: Straits Research New York, United States, April 29, 2024 (GLOBE NEWSWIRE) -- A drug infusion system is a medical device that allows fluids, medicines, and therapeutic substances to be administered directly into a...
SeaStar_SM_LogoCard.png
SeaStar Medical Provides Regulatory Update Related to its HDE Application for Pediatric Selective Cytopheretic Device
May 09, 2023 16:05 ET | SeaStar Medical Holding Corporation
DENVER, May 09, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...
Zion Market Research.jpg
Global Methenamine Hippurate Tablets Market Size is Anticipated to Acquire 6.51% Billion by 2030 With CAGR of 6.51% | Pharmaceuticals Industry Analysis
April 14, 2023 08:06 ET | Zion Market Research
Houston, TX, April 14, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Methenamine Hippurate Tablets Market By Application (Healthcare-Associated UTIs And...
Qualigen-Logo-Tag.png
Qualigen Therapeutics Announces Pre-IND Feedback from U.S. Food and Drug Administration Regarding QN-302 for the Treatment of G4-Targeted Advanced Solid Tumors
December 07, 2022 09:10 ET | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for...
gmi logo.jpg
Transradial Access Device Market revenue to cross USD 2.4 Bn by 2027: Global Market Insights Inc.
March 15, 2021 04:00 ET | Global Market Insights, Inc
Selbyville, Delaware, March 15, 2021 (GLOBE NEWSWIRE) -- According to latest report “Transradial Access Device Market by Product (Catheters, Guidewires, Sheath & Sheath Introducer,...
LOGO.jpg
Vivos Inc Achieves Important Radiogel™ Development Milestones
June 24, 2020 07:30 ET | Vivos Inc.
Richland WA, June 24, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos announced today significant progress in its efforts to advance RadioGel™ for human therapy. Animal testing at the...
Logo new.jpg
Vivos Inc. Reports Progress
April 30, 2019 07:00 ET | Vivos Inc.
Richland WA, April 30, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGL), provides an update on the progress towards commercialization of Y-90 IsoPet® for animal therapy. Animal...